Literature DB >> 32761885

Primary diffuse large B cell lymphoma of Uterine Cervix: Treatment outcomes of a rare entity with literature review.

Jayant Sastri Goda1, Utpal Gaikwad1, Anand Narayan1, Durva Kurkure1, Subhash Yadav1, Nehal Khanna1, Hasmukh Jain1, Bhausaheb Bagal1, Sridhar Epari1, Priya Singh1, Manju Sengar1, Siddharth Laskar1.   

Abstract

BACKGROUND: Primary lymphomas involving the female genital tract are rare, and those arising from cervix are extremely uncommon. They are often misdiagnosed because of their rarity. METHODS AND CASES: The treatment and clinical outcomes of the four cases treated at our institution were compared with the previously published studies. Written informed consent was taken. We highlight four cases of primary diffuse large B-cell lymphoma of cervix treated at our institution with immunochemotherapy and radiotherapy. The mean age was 50 years (range, 39-62 years). Three patients had stage I disease while one had stage II disease. All the patients were in complete remission following treatment with immunochemotherapy and radiation therapy. The average disease free survival was 20 months (range, 8-43 months). None of the patients had any local or systemic relapse.
CONCLUSION: These cases highlight the physicians to be aware of this entity as their management, natural history and prognosis is completely different from squamous carcinomas of the cervix. Surgery should not be attempted in these patients. Immunochemotherapy and radiotherapy results in favorable clinical outcomes.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  Immunochemotherapy; cervix; lymphoma; primary; radiation

Year:  2020        PMID: 32761885      PMCID: PMC7941478          DOI: 10.1002/cnr2.1264

Source DB:  PubMed          Journal:  Cancer Rep (Hoboken)        ISSN: 2573-8348


  39 in total

Review 1.  Clinicopathologic features of six cases of primary cervical lymphoma.

Authors:  John K Chan; Vera Loizzi; Alessandra Magistris; Mark I Hunter; Joanne Rutgers; Philip J DiSaia; Michael L Berman
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

2.  Sonographic features of primary lymphoma of the uterine cervix.

Authors:  Yvette Groszmann; Beryl R Benacerraf
Journal:  J Ultrasound Med       Date:  2013-04       Impact factor: 2.153

3.  CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.

Authors:  Michael Pfreundschuh; Evelyn Kuhnt; Lorenz Trümper; Anders Osterborg; Marek Trneny; Lois Shepherd; Devinder S Gill; Jan Walewski; Ruth Pettengell; Ulrich Jaeger; Pier-Luigi Zinzani; Ofer Shpilberg; Stein Kvaloy; Peter de Nully Brown; Rolf Stahel; Noel Milpied; Armando López-Guillermo; Viola Poeschel; Sandra Grass; Markus Loeffler; Niels Murawski
Journal:  Lancet Oncol       Date:  2011-09-21       Impact factor: 41.316

4.  Primary diffuse large B cell lymphoma of Uterine Cervix: Treatment outcomes of a rare entity with literature review.

Authors:  Jayant Sastri Goda; Utpal Gaikwad; Anand Narayan; Durva Kurkure; Subhash Yadav; Nehal Khanna; Hasmukh Jain; Bhausaheb Bagal; Sridhar Epari; Priya Singh; Manju Sengar; Siddharth Laskar
Journal:  Cancer Rep (Hoboken)       Date:  2020-08-06

5.  [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].

Authors:  Akari Hashimoto; Akihito Fujimi; Yuji Kanisawa; Teppei Matsuno; Toshinori Okuda; Shinya Minami; Tadashi Doi; Kazuma Ishikawa; Naoki Uemura; Yuko Jyomen; Utano Tomaru
Journal:  Gan To Kagaku Ryoho       Date:  2013-12

6.  Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.

Authors:  Bertrand Coiffier; Catherine Thieblemont; Eric Van Den Neste; Gérard Lepeu; Isabelle Plantier; Sylvie Castaigne; Sophie Lefort; Gérald Marit; Margaret Macro; Catherine Sebban; Karim Belhadj; Dominique Bordessoule; Christophe Fermé; Hervé Tilly
Journal:  Blood       Date:  2010-06-14       Impact factor: 22.113

7.  Full-term pregnancy and vaginal delivery after treatment for non-Hodgkin's lymphoma of the cervix and lower uterine segment: a case report.

Authors:  Mehdi Parva; Kathleen Lamb; Deric C Savior; Paul Gilman; Michael Belden
Journal:  J Obstet Gynaecol Can       Date:  2011-06

8.  Case Report of Diffuse Large B Cell Lymphoma of Uterine Cervix Treated at a Semiurban Cancer Centre in North India.

Authors:  Vibhor Sharma; Tapas Dora; Mehul Patel; Sankalp Sancheti; Epari Sridhar
Journal:  Case Rep Hematol       Date:  2016-08-11

9.  Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report.

Authors:  Ana María Cubo; Zandra Mileny Soto; Miguel Ángel Cruz; María José Doyague; Verónica Sancho; Aurymar Fraino; Óscar Blanco; Noemi Puig; Miguel Alcoceba; Marcos González; José María Sayagués
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

10.  Lymphoma of the cervix.

Authors:  Juanita Parnis; David J Camilleri; Darko Babic; James Degaetano; Charles Savona-Ventura
Journal:  Case Rep Hematol       Date:  2012-10-04
View more
  4 in total

1.  Primary diffuse large B cell lymphoma of Uterine Cervix: Treatment outcomes of a rare entity with literature review.

Authors:  Jayant Sastri Goda; Utpal Gaikwad; Anand Narayan; Durva Kurkure; Subhash Yadav; Nehal Khanna; Hasmukh Jain; Bhausaheb Bagal; Sridhar Epari; Priya Singh; Manju Sengar; Siddharth Laskar
Journal:  Cancer Rep (Hoboken)       Date:  2020-08-06

2.  Primary diffuse large B-Cell lymphoma of the uterine cervix with severe lower urinary tract Symptoms: A rare case report and review of the literature.

Authors:  Jiaosheng Li; Xiufen Zhang; You Liu; Qinhua Li; Yifan Guo; Haotian Yu
Journal:  Gynecol Oncol Rep       Date:  2022-09-06

3.  Hysteroscopic Resection Followed by Adjuvant Radiotherapy: Report of a New Therapeutic Approach to Primary Cervical Diffuse Large B-Cell Lymphoma.

Authors:  Guglielmo Stabile; Lara Sancin; Pierino Boschian Bailo; Chiara Ripepi; Andrea Romano; Stefania Carlucci; Giuseppe Ricci
Journal:  Int J Environ Res Public Health       Date:  2022-09-18       Impact factor: 4.614

Review 4.  Primary Non-Hodgkin Uterine Lymphoma of the Cervix: A Literature Review.

Authors:  Cristina Capsa; Laura Aifer Calustian; Sabina Antonela Antoniu; Eugen Bratucu; Laurentiu Simion; Virgiliu-Mihail Prunoiu
Journal:  Medicina (Kaunas)       Date:  2022-01-10       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.